SENS - Senseonics Holdings Inc
0.7552
-0.017 -2.198%
Share volume: 1,979,504
Last Updated: 04-25-2025
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.77
-0.02
-0.02%
Fundamental analysis
43%
Profitability
43%
Dept financing
25%
Liquidity
75%
Performance
40%
Performance
5 Days
2.46%
1 Month
11.80%
3 Months
-31.96%
6 Months
119.03%
1 Year
73.21%
2 Year
26.90%
Key data
Stock price
$0.76
DAY RANGE
$0.73 - $0.76
52 WEEK RANGE
$0.25 - $1.40
52 WEEK CHANGE
$73.21
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
Company detail

CEO: Timothy T. Goodnow
Region: US
Website: senseonics.com
Employees: 90
IPO year: 2016
Issue type: Common Stock
Market: NYSE American
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing
Region: US
Website: senseonics.com
Employees: 90
IPO year: 2016
Issue type: Common Stock
Market: NYSE American
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing
Senseonics Holdings, Inc. develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. Senseonics is headquartered in Germantown, Maryland, and serves healthcare providers and patients through a network of distributors.
Recent news
